White Paper

Considerations For Improving Patient Recruitment Into Clinical Trials

Imagine yourself to be a Fund Manager or Angel Investor considering an investment into the pharma or biotech industry and you become aware of the following statistics about recruitment of patients into clinical trials1:

  • Nearly 80% of all clinical studies fail to finish on time, and 20% of those are delayed for six months or more
  • 85% of clinical trials fail to retain enough patients
  • The average dropout rate across all clinical trials is around 30%
  • Over two-thirds of sites fail to meet original patient enrollment for a given trial
  • Up to 50% of sites enroll one or no patients in their studies

 

Clinical trials account for nearly 40% of the US pharma research budget and total around $7B per year and the estimated cost of patient recruitment is 40% of the total budget, or $1.89B. Thus, patient recruitment is the very weak link in the development pipeline and one that an experienced investor would want to know what steps are being taken to address the issue and thus accelerate the time to market and thus profitability.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: